Participants may not have had any prior history of hypertensive crisis or hypertensive encephalopathy
History of hypertensive crisis or hypertensive encephalopathy within 3 years
Prior history of hypertensive crisis or hypertensive encephalopathy
Patients with a history of hypertensive crisis or hypertensive encephalopathy within 6 months of study enrollment are not eligible
Any prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis, hypertensive encephalopathy, reversible posterior leukoencephalopathy syndrome (RPLS).
Has a known history of hypertensive crisis or hypertensive encephalopathy within 6 months prior to planned start of study drug
History of hypertensive crisis or hypertensive encephalopathy within 3 years of the randomization
(Bevacizumab-related exclusion) Prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
History of hypertensive crisis or hypertensive encephalopathy within 3 years prior to registration
Any prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Any prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive encephalopathy
Any prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Any prior history of hypertensive crisis or hypertensive encephalopathy
Patients are excluded if they have any prior history of hypertensive crisis or hypertensive encephalopathy
Any prior history of hypertensive crisis or hypertensive encephalopathy.
Prior history of hypertensive crisis or hypertensive encephalopathy
Has prior history of uncontrolled hypertension, hypertensive crisis or hypertensive encephalopathy
History of hypertensive crisis or hypertensive encephalopathy
Participants may not have had any prior history of hypertensive crisis or hypertensive encephalopathy
Has a history of hypertensive crisis or hypertensive encephalopathy
Current uncontrolled hypertension as well as prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Inadequately controlled hypertension or prior history of hypertensive crisis or hypertensive encephalopathy.
Prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Any prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Blood pressure of > 150/100 mmHg, history of hypertensive crisis or hypertensive encephalopathy
Any prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Have a history of hypertensive crisis or hypertensive encephalopathy or current poorly controlled hypertension despite standard medical management.
Prior history of hypertensive crisis or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy
Inadequately controlled hypertension or history of hypertensive crisis or encephalopathy.
History of hypertensive crisis or hypertensive encephalopathy
Blood pressure must be well-controlled (less than or equal to 140/90 mmHg at screening) with or without antihypertensive medication. Patients must have no history of hypertensive crisis or hypertensive encephalopathy;
Patients with hypertensive crises or hypertensive encephalopathy
Prior history of hypertensive crisis or hypertensive encephalopathy within the previous 3 months of first study treatment
Prior history of hypertensive crisis or hypertensive encephalopathy